Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5338936 | 0.75 | — | — | |
| SCHEMBL5917732 | 0.72 | MCHR1 (0.35) | MEN1NPC1RAB9AKMT2AMCHR1 | |
| SCHEMBL5559403 | 0.71 | ATM (0.39) | — | |
| SCHEMBL13018439 | 0.69 | MEN1 (0.35) | MEN1NPC1RAB9AKMT2AMCHR1 | |
| SCHEMBL9517788 | 0.69 | MEN1 (0.41) | MEN1NPC1RAB9AKMT2ASCN9A | |
| SCHEMBL13188783 | 0.69 | MEN1 (0.40) | MEN1NPC1RAB9AKMT2AMCHR1 | |
| SCHEMBL19055333 | 0.69 | MCHR1 (0.37) | MEN1NPC1RAB9AKMT2AMCHR1 | |
| SCHEMBL21466550 | 0.69 | MCHR1 (0.37) | MEN1NPC1RAB9AKMT2AMCHR1 | |
| SCHEMBL18379791 | 0.69 | MCHR1 (0.37) | MEN1NPC1RAB9AKMT2AMCHR1 | |
| SCHEMBL18714955 | 0.69 | MCHR1 (0.37) | MEN1NPC1RAB9AKMT2AMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7220810-B2 | Polymer film and method for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7217830-B2 | Organic silicon compound and method for preparing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-15 | — | — | US | disclosed |
| US-20060009600-A1 | Polymer film and method for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-01-12 | — | — | US | disclosed |
| US-20060004219-A1 | Organic silicon compound and method for preparing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004219-A1 | Organic silicon compound and method for preparing the same | AR, PKD1, SKP2 | MEN1 68/4885NPC1 187/4885RAB9A 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.